PAVM News and Press, PAVmed Inc. From 02/28/23

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...

PAVmed Digital Health Subsidiary Veris Health's Veris Cancer Care Platform™ Goes Live PR Newswire Remote patient monitoring of first cohort of cancer patients using VerisBox ™ connected devices and Veris CCP smartphone app initiated Cancer care team u...

Lucid Diagnostics Holds First #CheckYourFoodTube Precancer Testing Event PR Newswire Partners with San Antonio Fire Department to test nearly 400 firefighters for esophageal precancer during Firefighter Cancer Awareness Month over two weekends, averaging nearly 100 tests p...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...

PAVmed ( NASDAQ: PAVM ) on Tuesday, along with its units Lucid Diagnostics ( NASDAQ: LUCD ) and Veris Health, announced strategic changes which include workforce reduction and other cost-cutting measures. The companies said they would prioritize near-term Lucid and Veris Healt...

Strategic resource reallocation, including workforce reduction and other cost-cutting measures, to prioritize near-term Lucid and Veris Health commercialization efforts Conference call to be held today at 4:30PM EDT PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a d...

Companies to host Conference Call at 4:30 PM EDT on Tuesday, January 17, 2023 PAVmed Inc. (Nasdaq: PAVM, PAVMZ), a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors, and its majority-owned subsidiaries Lu...

License option and joint R&D agreement seek to apply Novosound’s groundbreaking flexible thin-film ultrasound technology to intravascular imaging PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (“PAVmed”), a diversified commercial-stage medical technology company...

Executes first commercial contract with leading New Jersey oncology practice PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (“PAVmed”), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, toda...